Patrick A Ott Selected Research

Patrick A Ott Research Topics

Disease

88	Melanoma (Melanoma, Malignant) 04/2024 - 01/2009
88	Neoplasms (Cancer) 04/2024 - 01/2010
13	Disease Progression 01/2022 - 05/2015
11	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2011
8	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2009
8	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 03/2013
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 02/2015
7	Colitis 01/2021 - 11/2016
5	Pneumonia (Pneumonitis) 08/2021 - 07/2016
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 06/2017
4	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2020
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2005 - 09/2002
3	COVID-19 04/2024 - 05/2021
3	Fatigue 03/2024 - 01/2009
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 07/2016
3	Uveal melanoma 12/2018 - 10/2013
3	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 01/2016
3	Exanthema (Rash) 01/2017 - 01/2009
2	Dermatitis 03/2024 - 08/2021
2	Squamous Cell Carcinoma of Head and Neck 03/2024 - 10/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022 - 12/2017
2	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2016
2	Inflammation (Inflammations) 01/2019 - 03/2013
2	Carcinoma (Carcinomatosis) 01/2019 - 11/2016
2	Endometrial Neoplasms (Endometrial Cancer) 12/2017 - 08/2017
2	Hypothyroidism 12/2017 - 01/2017
2	Hypophysitis 11/2016 - 02/2015
2	Renal Insufficiency (Renal Failure) 07/2016 - 01/2013
2	Testicular Neoplasms (Testicular Cancer) 03/2015 - 06/2013
2	Infections 03/2013 - 02/2004
2	Thrombocytopenia (Thrombopenia) 01/2013 - 01/2009
2	Neutropenia 01/2013 - 01/2009
2	Chronic Disease (Chronic Diseases) 02/2004 - 09/2002
1	Colorectal Neoplasms (Colorectal Cancer) 03/2024
1	Skin Neoplasms (Skin Cancer) 01/2024

Drug/Important Bio-Agent (IBA)

57	Immune Checkpoint InhibitorsIBA 03/2024 - 06/2013
27	IpilimumabIBA 01/2024 - 06/2013
22	pembrolizumabIBA 01/2024 - 02/2015
18	NivolumabIBA 04/2024 - 02/2015
17	VaccinesIBA 04/2024 - 06/2014
16	Monoclonal AntibodiesIBA 03/2024 - 03/2013
14	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2023 - 02/2013
10	AntigensIBA 01/2023 - 02/2004
9	B7-H1 AntigenIBA 11/2022 - 08/2017
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2013
8	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2004
8	LigandsIBA 01/2020 - 03/2013
7	CytokinesIBA 11/2021 - 09/2002
6	Cancer VaccinesIBA 04/2024 - 01/2018
6	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2021 - 02/2015
5	EpitopesIBA 04/2024 - 07/2004
5	CTLA-4 AntigenIBA 10/2022 - 06/2013
5	Peptides (Polypeptides)IBA 01/2021 - 02/2004
5	AntibodiesIBA 01/2017 - 01/2014
4	trametinibIBA 06/2023 - 02/2013
4	VemurafenibIBA 01/2023 - 04/2013
3	dabrafenibIBA 06/2023 - 01/2014
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2019
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 06/2014
3	CreatinineIBA 01/2019 - 01/2013
3	EnzymesIBA 01/2015 - 02/2004
2	Protein Subunit VaccinesIBA 04/2024 - 01/2021
2	RNA (Ribonucleic Acid)IBA 04/2024 - 11/2018
2	tremelimumabIBA 02/2024 - 11/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 01/2015
2	Imiquimod (Aldara)FDA LinkGeneric 01/2023 - 09/2022
2	Death Domain ReceptorsIBA 10/2022 - 11/2016
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021 - 01/2011
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 03/2013
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2021
2	ProdrugsIBA 01/2021 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2017
2	Monatide (IMS 3015)IBA 01/2020 - 03/2015
2	glembatumumab vedotinIBA 01/2019 - 11/2014
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 11/2014
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 11/2014
2	Interleukin-10 (Interleukin 10)IBA 11/2018 - 10/2016
2	AutoantigensIBA 01/2018 - 07/2004
2	Phosphotransferases (Kinase)IBA 01/2017 - 10/2013
2	PlatinumIBA 11/2016 - 07/2016
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016 - 09/2015
2	Cytotoxins (Cytolysins)IBA 11/2014 - 01/2011
2	Mitogen-Activated Protein KinasesIBA 01/2014 - 04/2013
2	Dacarbazine (DIC)FDA LinkGeneric 01/2013 - 01/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2024
1	Vancomycin FDA LinkGeneric 04/2024
1	Cetuximab (Erbitux)FDA Link 03/2024
1	urelumabIBA 03/2024
1	Prednisone (Sone)FDA LinkGeneric 01/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2024
1	prednylidene (Pred)IBA 01/2024
1	afliberceptIBA 01/2024
1	cobimetinibIBA 01/2023
1	LY3022855IBA 01/2023

Therapy/Procedure

64	Therapeutics 03/2024 - 06/2009
32	Immunotherapy 03/2024 - 02/2013
13	Drug Therapy (Chemotherapy) 01/2022 - 01/2009
8	Radiotherapy 01/2021 - 07/2013
4	Aftercare (After-Treatment) 01/2023 - 01/2017